These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy. Strutt K; Caplan R; Hutchison H; Dane A; Blasetto J Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143 [TBL] [Abstract][Full Text] [Related]
43. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129 [TBL] [Abstract][Full Text] [Related]
44. More on PROSPER. Baztán JJ; Hornillos M; Rodríguez-Mañas L Lancet; 2003 Mar; 361(9363):1135; author reply 1136. PubMed ID: 12672345 [No Abstract] [Full Text] [Related]
45. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies. Elam MB; Cushman W; Applegate WB; Heimberg M Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876 [No Abstract] [Full Text] [Related]
46. Cholesterol hypothesis vindicated by simvastatin study. Why did it take so long? Beamish RE; Dhalla NS Can J Cardiol; 1995 Mar; 11(3):191-2. PubMed ID: 7889435 [No Abstract] [Full Text] [Related]
47. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia. Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300 [TBL] [Abstract][Full Text] [Related]
48. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias]. Carmena R Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284 [No Abstract] [Full Text] [Related]
49. Acute pancreatitis due to pravastatin therapy. Anagnostopoulos GK; Tsiakos S; Margantinis G; Kostopoulos P; Arvanitidis D JOP; 2003 May; 4(3):129-32. PubMed ID: 12743419 [TBL] [Abstract][Full Text] [Related]
51. Benefits and menaces related to the use of statins in patients after renal transplantation. Chmielewski M; Zdrojewski Z; Rutkowski B Ann Transplant; 2002; 7(2):6-10. PubMed ID: 12416466 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
53. How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Phillips PS Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453 [No Abstract] [Full Text] [Related]
55. Clinical investigation on the hypolipidemic effect of simvastatin in primary hypercholesterolemia. Saba P; Galeone F; Giuntoli F; Spagnolo G; Brunelleschi G; Lamanna F; Angelé B Clin Ter; 1992 Jan; 140(1 Pt 2):3-9. PubMed ID: 1559319 [TBL] [Abstract][Full Text] [Related]
56. Current perspectives on statins. Mishra TK; Routray S J Indian Med Assoc; 2003 Jun; 101(6):381-3. PubMed ID: 14579987 [TBL] [Abstract][Full Text] [Related]
57. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin. Emmerich J Am J Cardiol; 1994 Apr; 73(9):723-4. PubMed ID: 8166080 [No Abstract] [Full Text] [Related]
58. [Ezetimibe: from pharmacology to clinical trials]. Tellier P Ann Endocrinol (Paris); 2003 Dec; 64(6):442-7. PubMed ID: 15067249 [TBL] [Abstract][Full Text] [Related]